Vinca alkaloids.
Chabner
B A
BA
Horwitz
S B
SB
Clendennin
N J
NJ
Purvis
J D
JD
D000470:Alkaloids / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D003131:Combined Modality Therapy; D004347:Drug Interactions; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy / Q000628:therapy; D017239:Paclitaxel; D014747:Vinblastine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D014748:Vinca Alkaloids / Q000627:therapeutic use*; D014750:Vincristine / Q000627:therapeutic use; D000077235:Vinorelbine
D000470:Alkaloids; D014748:Vinca Alkaloids; D014750:Vincristine; D014747:Vinblastine; D017239:Paclitaxel; D000077235:Vinorelbine